immune-checkpoint-inhibitors

Documents about immune-checkpoint-inhibitors

• Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)#994055ClinicalTrials.gov
• Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma#835507ClinicalTrials.gov
• Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer#812371ClinicalTrials.gov
• Real World Pharmacokinetics of Immune Checkpoint Inhibitors#992775ClinicalTrials.gov
• Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer#1032878ClinicalTrials.gov
• Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy#1009917ClinicalTrials.gov
• Machine learning approaches to predict early cardiac immune-related adverse events in patients receiving immune checkpoint inhibitors#1054557OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma#902306ClinicalTrials.gov
• Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors#268893IRIS
• Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS#912776ClinicalTrials.gov
• Predictive value of baseline eosinophil counts for immune-related adverse events in metastatic NSCLC treated with immune checkpoint inhibitors#386527ARPHA OAI-PMH Endpoint
• Gene-level gut microbiome signatures as predictive biomarkers for response to immune checkpoint inhibitors across multiple cancer types.#136108PubMed
• Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer#840354ClinicalTrials.gov
• Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study#294704HAL (France)
• Evaluating Urinary Biomarkers for Early Detection of Kidney Damage in Immune Checkpoint Inhibitors-Treated Patients#291401Gestión del Repositorio Documental de la Universidad de Salamanca
• Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors#875905ClinicalTrials.gov
• Artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis of the landscape.#412895PubMed
• A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy#448275ClinicalTrials.gov
• Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC#811484ClinicalTrials.gov
• Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis#889893ClinicalTrials.gov
• Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer#4693Europe PMC
• Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors#873179ClinicalTrials.gov
• PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure#864722ClinicalTrials.gov
• Cancer Nutrition Study - A Study of Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors#982591ClinicalTrials.gov
• The peripheral immune landscape of human breast cancer#642697Europe PMC
• Fertility and Pregnancy After Avelumab Treatment#125842ClinicalTrials.gov
• Genetic Determinants of Myocarditis Induced by Immune-checkpoint Inhibitors#226248ClinicalTrials.gov
• DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER#454023ClinicalTrials.gov
• Association Of Immune Checkpoint Inhibitor Approval On Suicide Rates Among Patients With Cancer: A Pre-Post Analysis With Seer#167490EliScholar
• Investigating B Cell Function and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia.#305924ResearchSpace
• The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors#875335ClinicalTrials.gov
• Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer#268016ClinicalTrials.gov
• CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.#353279ClinicalTrials.gov
• ICIAM Rehabilitation Program Study: A Randomized Controlled Trial#369833ClinicalTrials.gov
• Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer#411395ClinicalTrials.gov
• Guillain–Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study#676798HAL (France)
• Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma#677166HAL (France)
• Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature#893644ClinicalTrials.gov
• Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors#881858ClinicalTrials.gov
• Neutrophil-to-lymphocyte ratio affects the impact of proton pump inhibitors on efficacy of immune checkpoint inhibitors in patients with non‑small-cell lung cancer#194772OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies#633718ClinicalTrials.gov
• Machine learning approaches to predict early cardiac immune-related adverse events in patients receiving immune checkpoint inhibitors.#415654NCBI PubMed Central
• B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non–drug-related lichen planus#471876HAL (France)
• Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer#839698ClinicalTrials.gov
• JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors#882723ClinicalTrials.gov
• Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment#830950ClinicalTrials.gov
• Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies.#368100NCBI PubMed Central
• Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives#120190Europe PMC
• Pseudohypoxia induced by iron chelator activates tumor immune response in lung cancer#194773OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Antibiotic use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database.#214053NCBI PubMed Central

Related topics